The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions

Introduction: Prostate-specific antigen velocity (PSAV) is used to monitor men with clinical suspicion of prostate cancer (PCa), with a normal cut-off point of 0.3–0.5 ng/mL/year. The aim of the study is to establish the predictive capacity of PSAV (value and acceleration) and of the free PSA/total...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Flores-Fraile, María-Carmen, Padilla-Fernández, Bárbara Yolanda, Valverde-Martínez, Sebastián, Marquez-Sanchez, Magaly, García-Cenador, María-Begoña, Lorenzo-Gómez, María-Fernanda, Flores-Fraile, Javier
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7690774/
https://ncbi.nlm.nih.gov/pubmed/33114134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113400
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars